TP53 and neoplasm: Since the tumor from which the ZMEL1 line was initiated with only 2 genetic lesions, BRAFV600E activation and p53 loss of function, characterization of its genome gave us an opportunity to characterize further genetic evolution that contributed to tumor formation over these 6 months.